<DOC>
	<DOCNO>NCT01593904</DOCNO>
	<brief_summary>1 . What true incidence CCSVI patient MS study compare MRI MS patient control . 2 . Are beneficial outcome treatment placebo ? By measure change brain perfusion Cerebrospinal flow procedure large number patient determine outcome</brief_summary>
	<brief_title>Venous Irregularities , Flow Perfusion MS Study</brief_title>
	<detailed_description>The purpose study compare MS subject non-MS , non-blood related subject . The 3D structural information provide protocol combine ability observe quantify flow major vessel neck , well azygous vein , make ideal method evaluate subject ' venous outflow . The protocol also potential confirm diagnosis Multiple Sclerosis , observe change parenchyma , well provide data potential co-morbidity may previously overlook non-emergent . The baseline scan data acquire normal pre-treatment MS patient track longitudinally MSpatients change : arterial venous cross sectional area ; morphological change vessel , brain structure , lesion ; flow distribution flow pattern artery , vein , cerebrospinal fluid ( CSF ) ; iron quantification deep basal ganglia thalamus ; parenchymal lesion volume morphology ; atrophy ratio gray matter , white matter ; CSF intracranial space ; appearance intracranial vein potential iron lesion parenchyma . A major benefit MRI independent operator bias acquisition easily reproduce .</detailed_description>
	<criteria>Ability comprehend nature study , include risk benefit Ability execute inform consent Males Females age 20 65 year age Voluntary agreement participate study : Venous Irregularities , Flow Perfusion MS study ( VERIFY MS Study ) Any implantable/metallic object prevents subject magnetic resonance imaging ( MRI/MRV ) study . Any person contraindication contrast administration . History claustrophobia Special Populations . Special group include , limited child , prisoner , pregnant woman , fetus , cognitively impaired individual unable provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>CCSVI , Flow , Perfusion MS</keyword>
</DOC>